These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 30992362)
1. Phosphorylation of HSP90 by protein kinase A is essential for the nuclear translocation of androgen receptor. Dagar M; Singh JP; Dagar G; Tyagi RK; Bagchi G J Biol Chem; 2019 May; 294(22):8699-8710. PubMed ID: 30992362 [TBL] [Abstract][Full Text] [Related]
2. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells. Tsui KH; Chang YL; Feng TH; Hou CP; Lin YH; Yang PS; Lee BW; Juang HH Prostate; 2018 Mar; 78(4):242-249. PubMed ID: 29164633 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of androgen receptors by NaAsO Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958 [TBL] [Abstract][Full Text] [Related]
4. Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer. Sarwar M; Sandberg S; Abrahamsson PA; Persson JL Urol Oncol; 2014 Jan; 32(1):25.e1-12. PubMed ID: 23410945 [TBL] [Abstract][Full Text] [Related]
5. The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus. Kim J; Jia L; Stallcup MR; Coetzee GA J Mol Endocrinol; 2005 Feb; 34(1):107-18. PubMed ID: 15691881 [TBL] [Abstract][Full Text] [Related]
6. 2,2-bis(4-chlorophenyl)-1,1-dichloroethylene stimulates androgen independence in prostate cancer cells through combinatorial activation of mutant androgen receptor and mitogen-activated protein kinase pathways. Shah S; Hess-Wilson JK; Webb S; Daly H; Godoy-Tundidor S; Kim J; Boldison J; Daaka Y; Knudsen KE Mol Cancer Res; 2008 Sep; 6(9):1507-20. PubMed ID: 18819937 [TBL] [Abstract][Full Text] [Related]
7. Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer. Reebye V; Querol Cano L; Lavery DN; Brooke GN; Powell SM; Chotai D; Walker MM; Whitaker HC; Wait R; Hurst HC; Bevan CL Mol Endocrinol; 2012 Oct; 26(10):1694-706. PubMed ID: 22899854 [TBL] [Abstract][Full Text] [Related]
8. Activation of GPR56, a novel adhesion GPCR, is necessary for nuclear androgen receptor signaling in prostate cells. Singh JP; Dagar M; Dagar G; Kumar S; Rawal S; Sharma RD; Tyagi RK; Bagchi G PLoS One; 2020; 15(9):e0226056. PubMed ID: 32881870 [TBL] [Abstract][Full Text] [Related]
9. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells. Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946 [TBL] [Abstract][Full Text] [Related]
10. Androgens transduce the G alphas-mediated activation of protein kinase A in prostate cells. Bagchi G; Wu J; French J; Kim J; Moniri NH; Daaka Y Cancer Res; 2008 May; 68(9):3225-31. PubMed ID: 18451148 [TBL] [Abstract][Full Text] [Related]
11. The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cells. Dar JA; Masoodi KZ; Eisermann K; Isharwal S; Ai J; Pascal LE; Nelson JB; Wang Z J Steroid Biochem Mol Biol; 2014 Sep; 143():473-80. PubMed ID: 24662325 [TBL] [Abstract][Full Text] [Related]
12. The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells. Saporita AJ; Ai J; Wang Z Prostate; 2007 Apr; 67(5):509-20. PubMed ID: 17221841 [TBL] [Abstract][Full Text] [Related]
13. Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways. Sadar MD J Biol Chem; 1999 Mar; 274(12):7777-83. PubMed ID: 10075669 [TBL] [Abstract][Full Text] [Related]
14. Camptothecin disrupts androgen receptor signaling and suppresses prostate cancer cell growth. Liu S; Yuan Y; Okumura Y; Shinkai N; Yamauchi H Biochem Biophys Res Commun; 2010 Apr; 394(2):297-302. PubMed ID: 20206136 [TBL] [Abstract][Full Text] [Related]
15. Berberine suppresses androgen receptor signaling in prostate cancer. Li J; Cao B; Liu X; Fu X; Xiong Z; Chen L; Sartor O; Dong Y; Zhang H Mol Cancer Ther; 2011 Aug; 10(8):1346-56. PubMed ID: 21613449 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52. Joshi JB; Patel D; Morton DJ; Sharma P; Zou J; Hewa Bostanthirige D; Gorantla Y; Nagappan P; Komaragiri SK; Sivils JC; Xie H; Palaniappan R; Wang G; Cox MB; Chaudhary J Mol Oncol; 2017 Apr; 11(4):337-357. PubMed ID: 28252832 [TBL] [Abstract][Full Text] [Related]
17. Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity. Zoubeidi A; Zardan A; Beraldi E; Fazli L; Sowery R; Rennie P; Nelson C; Gleave M Cancer Res; 2007 Nov; 67(21):10455-65. PubMed ID: 17974989 [TBL] [Abstract][Full Text] [Related]
18. Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A. Desiniotis A; Schäfer G; Klocker H; Eder IE Int J Cancer; 2010 Feb; 126(3):775-89. PubMed ID: 19653278 [TBL] [Abstract][Full Text] [Related]
19. Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer. Moon SJ; Jeong BC; Kim HJ; Lim JE; Kim HJ; Kwon GY; Jackman JA; Kim JH Theranostics; 2021; 11(2):958-973. PubMed ID: 33391515 [No Abstract] [Full Text] [Related]
20. A naturally derived small molecule disrupts ligand-dependent and ligand-independent androgen receptor signaling in human prostate cancer cells. Amin KS; Jagadeesh S; Baishya G; Rao PG; Barua NC; Bhattacharya S; Banerjee PP Mol Cancer Ther; 2014 Feb; 13(2):341-52. PubMed ID: 24258347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]